AOD-9604 in Katzenelnbogen — Fat Loss Peptide Research Guide
AOD-9604 research guide for Katzenelnbogen. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
For anyone in Katzenelnbogen looking to source AOD-9604, the foundational reality is that this compound moves through online research channels. What this means for Katzenelnbogen researchers is that geography is secondary to your ability to verify analytical documentation — and those quality checks are accessible to anyone. A legitimate AOD-9604 supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all traceable to your specific batch. The sections below cover what Katzenelnbogen researchers need to know about purchasing, testing, and working with AOD-9604 for scientific research use.
The Science Behind AOD-9604
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: AOD-9604 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Katzenelnbogen comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
Where to Buy AOD-9604 — A Researcher's Guide
The most reliable path to quality AOD-9604 is engaging research communities before vendor sites — peptide forums aggregate real purchasing experience that are more trustworthy than marketing materials. When reviewing a AOD-9604 COA, verify: the batch number traces to your order, HPLC purity is ≥98%, mass spec establishes identity, and endotoxin levels are at acceptable levels for the intended application. Red flags in AOD-9604 vendor evaluation: prices more than 30-40% below standard market rates, vague sourcing information, no community presence, and COAs that omit endotoxin testing. Bacteriostatic water is the standard reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that inhibits bacterial growth and extends reconstituted shelf life to approximately one month when stored at 2-8°C.
Order AOD-9604 — ships to Katzenelnbogen
COA-verified · International tracking · Research grade
All use of AOD-9604 in Katzenelnbogen or anywhere constitutes research use — this compound is not approved for therapeutic human application, and all handling should follow research laboratory protocols. Storage requirements for AOD-9604: lyophilised powder at −20°C, reconstituted solution stored refrigerated at 2-8°C and consumed within 4 weeks; reconstitute only with bac water. Endotoxin testing in the AOD-9604 COA is not optional — gram-negative bacterial endotoxins can trigger severe inflammatory responses at minute levels, and no pricing advantage justifies skipping this verification. For any individual considering AOD-9604 outside a formal research context: seek medical advice first — this compound is unapproved for human therapeutic application and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
